Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Streptococcal Infections and Treatments, Dermatological diseases and infestations, Antimicrobial Resistance in Staphylococcus, and Infective Endocarditis Diagnosis and Management.
Inter-species gene flow drives ongoing evolution of Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis
Humoral and cellular immune responses in vaccinated and unvaccinated children following SARS‐CoV‐2 Omicron infection
2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease
Promiscuous evolution of Group A Streptococcal M and M-like proteins
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial
Comparison of Seroconversion in Children and Adults With Mild COVID-19
Comparison of antibody responses to SARS-CoV-2 variants in Australian children
The body distribution of scabies skin lesions
Diagnostics to support the control of scabies–Development of two target product profiles
Statistical concerns for meta-analysis of rare events and small sample sizes – Authors' reply
A framework for scabies control
A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication?
Health-related quality of life impact of scabies in the Solomon Islands
Defining the need for public health control of scabies in Solomon Islands
Estimation of scabies prevalence using simplified criteria and mapping procedures in three Pacific and southeast Asian countries
Children and Adults in a Household Cohort Study Have Robust Longitudinal Immune Responses Following SARS-CoV-2 Infection or Exposure
Persistence of SARS-CoV-2–Specific IgG in Children 6 Months After Infection, Australia
The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies
Estimating the global burden of scabies: what else do we need?*
Analysis of Global Collection of Group A <i>Streptococcus</i> Genomes Reveals that the Majority Encode a Trio of M and M-Like Proteins
Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)
The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans
Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to <i>Strongyloides stercoralis</i> in Children
The cost-of-illness due to rheumatic heart disease: national estimates for Fiji
Towards a comprehensive research and development plan to support the control, elimination and eradication of neglected tropical diseases
The public health control of scabies: priorities for research and action
Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics
The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics
Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial
Prevalence of scabies and impetigo in the Solomon Islands: a school survey